Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 2005

Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts

  • Monique Akoachere , Rimma Iozef , Stefan Rahlfs , Marcel Deponte , Bengt Mannervik , Donald J. Creighton , Heiner Schirmer and Katja Becker
From the journal Biological Chemistry

Abstract

The glyoxalase system consisting of glyoxalase I (GloI) and glyoxalase II (GloII) constitutes a glutathione-dependent intracellular pathway converting toxic 2-oxoaldehydes, such as methylglyoxal, to the corresponding 2-hydroxyacids. Here we describe a complete glyoxalase system in the malarial parasite Plasmodium falciparum. The biochemical, kinetic and structural properties of cytosolic GloI (cGloI) and two GloIIs (cytosolic GloII named cGloII, and tGloII preceded by a targeting sequence) were directly compared with the respective isofunctional host enzymes. cGloI and cGloII exhibit lower Km values and higher catalytic efficiencies (kcat/Km) than the human counterparts, pointing to the importance of the system in malarial parasites. A Tyr185Phe mutant of cGloII shows a 2.5-fold increase in Km, proving the contribution of Tyr185 to substrate binding. Molecular models suggest very similar active sites/metal binding sites of parasite and host cell enzymes. However, a fourth protein, which has highest similarities to GloI, was found to be unique for malarial parasites; it is likely to act in the apicoplast, and has as yet undefined substrate specificity. Various S-(N-hydroxy-N-arylcarbamoyl)glutathiones tested as P. falciparum Glo inhibitors were active in the lower nanomolar range. The Glo system of Plasmodium will be further evaluated as a target for the development of antimalarial drugs.

:

Corresponding author

References

Antognelli, C., Romani, R., Baldrachini, F., De Santis, A., Andreani, G., and Talesa, V. (2003). Different activity of glyoxalase system enzymes in specimens of Sparus auratus exposed to sublethal copper concentrations. Chem. Biol. Interact.142, 297–305.10.1016/S0009-2797(02)00124-2Search in Google Scholar

Armstrong, R.N. (2000). Mechanistic diversity in a metalloenzyme superfamily. Biochemistry39, 13625–13632.10.1021/bi001814vSearch in Google Scholar

Aronsson, A.C., Sellin, S., Tibbelin, G., and Mannervik, B. (1981). Probing the active site of glyoxalase I from human erythrocytes by use of the strong reversible inhibitor S-p-bromobenzylglutathione and metal substitutions. Biochem. J.197, 67–75.10.1042/bj1970067Search in Google Scholar

Biswas, S., Gairola, C.G., and Das, S.K. (2002). Passive cigarette smoke and the renal glyoxalase system. Mol. Cell. Biochem.229, 153–156.10.1023/A:1017992403656Search in Google Scholar

Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.72, 248–254.10.1016/0003-2697(76)90527-3Search in Google Scholar

Cameron, A.D., Ridderström, M., Olin, B., Kavarana, M.J., Creighton, D.J., and Mannervik, B. (1999a). Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue. Biochemistry38, 13480–13490.10.1021/bi990696cSearch in Google Scholar

Cameron, A.D., Ridderström, M., Olin, B., and Mannervik, B. (1999b). Crystal structure of human glyoxalase II and its complex with a glutathione thiolester substrate analogue. Struct. Fold. Des.7, 1067–1078.10.1016/S0969-2126(99)80174-9Search in Google Scholar

Clugston, S.L. and Honek, J.F. (2000). Identification of sequences encoding the detoxification metalloisomerase glyoxalase I in microbial genomes from several pathogenic organisms. J. Mol. Evol.50, 491–495.10.1007/s002390010052Search in Google Scholar PubMed

Clugston, S.L., Daub, E., and Honek, J.F. (1998). Identification of glyoxalase I sequences in Brassica oleracea and Sporobolus stapfianus: evidence for gene duplication events. J. Mol. Evol.47, 230–234.10.1007/PL00006380Search in Google Scholar PubMed

Cordell, P.A., Futers, S., Grant, P.J., and Pease, R.J. (2004). The human hydroxyacylglutathione hydrolase (HAGH) gene encodes both cytosolic and mitochondrial forms of glyoxalase II. J. Biol. Chem.279, 28653–28661.10.1074/jbc.M403470200Search in Google Scholar PubMed

Creighton, D.J., Zheng, Z.B., Holewinski, R., Hamilton, D.S., and Eiseman, J.L. (2003). Glyoxalase I inhibitors in cancer chemotherapy. Biochem. Soc. Trans.31,1378–1382.10.1042/bst0311378Search in Google Scholar

Crowder, M.W., Maiti, M.K., Banovic, L., and Makaroff, C.A. (1997). Glyoxalase II from Arabidopsis thaliana requires Zn(II) for catalytic activity. FEBS Lett.418, 351–354.10.1016/S0014-5793(97)01416-6Search in Google Scholar

Daiyasu, H., Osaka, K., Ishino, Y., and Toh, H. (2001). Expansion of the zinc metallo-hydrolase family of the β-lactamase fold. FEBS Lett.503, 1–6.10.1016/S0014-5793(01)02686-2Search in Google Scholar

Frickel, E-M., Jemth, P., Widersten, M., and Mannervik, B. (2001). Yeast glyoxalase I is a monomeric enzyme with two active sites. J. Biol. Chem.276, 1845–1849.10.1074/jbc.M005760200Search in Google Scholar

Gardner, M.J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R.W., Carlton, J.M., Pain, A., Nelson, K.E., Bowman, S., et al. (2002). The genome sequence of the human malaria parasite Plasmodium falciparum. Nature419, 498–511.10.1038/nature01097Search in Google Scholar

Greenwood, B. and Mutabwinga, T. (2002). Malaria in 2002. Nature415, 670–672.10.1038/415670aSearch in Google Scholar

Guex, N. and Peitsch, M.C. (1997). SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis18, 2714–2723.10.1002/elps.1150181505Search in Google Scholar

Hamilton, D.S. and Creighton, D.J. (1992). Inhibition of glyoxalase I by the enediol mimic S-(N-hydroxy-N-methylcarbamoyl)glutathione – the possible basis of a tumor-selective anticancer strategy. J. Biol. Chem.267, 24933–24936.10.1016/S0021-9258(19)73986-6Search in Google Scholar

Hamilton, D.S., Kavarana, M.J., Sharkey, E.M., Eiseman, J.L., and Creighton, D.J. (1999). A new method for rapidly generating inhibitors of glyoxalase I inside tumor cells using S-(N-aryl-N-hydroxycarbamoyl)ethylsulfoxides. J. Med. Chem.42, 1823–1827.10.1021/jm980712oSearch in Google Scholar

Iozef, R., Rahlfs, S., Chang, T., Schirmer, H., and Becker, K. (2003). Glyoxalase I of the malarial parasite Plasmodium falciparum: evidence for subunit fusion. FEBS Lett.554, 284–288.10.1016/S0014-5793(03)01146-3Search in Google Scholar

Irsch, T. and Krauth-Siegel, R.L. (2004). Glyoxalase II of African trypanosomes is trypanothione-dependent. J. Biol. Chem.279, 22209–22217.10.1074/jbc.M401240200Search in Google Scholar

Jacobasch, G., Buckwitz, D., Gerth, C., and Thamm, R. (1990). Regulation of the energy metabolism of Plasmodium berghei. Biomed. Biochim. Acta49, 289–294.Search in Google Scholar

Kalsi, A., Kavarana, M.J., Lu, T., Whalen, D.L., Hamilton, D.S., and Creighton, D.J. (2000). Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumour target enzyme glyoxalase I. J. Med. Chem.43, 3981–3986.10.1021/jm000160lSearch in Google Scholar

Kavarana, M.J., Kovaleva, E.G., Creighton, D.J., Wollman, M.B., and Eiseman, J.L. (1999). Mechanism-based competitive inhibitors of glyoxalase I: intracellular delivery, in vitro antitumor activities, and stabilities in human serum and mouse serum. J. Med. Chem.42, 221–228.10.1021/jm9708036Search in Google Scholar

Lo, T.W.C. and Thornalley, P.J. (1992). Inhibition of proliferation of human leukaemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro. Biochem. Pharmacol.44, 2357–2363.10.1016/0006-2952(92)90680-HSearch in Google Scholar

Lo, T.W.C., Westwood, M.E., McLellan, A.C., Selwood, T., and Thornalley, P.J. (1994). Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with Nα-acetylarginine, Nα-acetylcysteine, Nα-acetyl-lysine, and bovine serum albumin. J. Biol. Chem.269, 32299–32305.Search in Google Scholar

Marmstål, E., Aronsson, A.C., and Mannervik, B. (1979). Comparison of glyoxalase I purified from yeast (Saccharomyces cerevisiae) with the enzyme from mammalian sources. Biochem. J.183, 23–30.10.1042/bj1830023Search in Google Scholar

Mearini, E., Romani, R., Mearini, L., Antognelli, C., Zucchi, A., Baroni, T., Porena, M., and Talesa, V.N. (2002). Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas. Eur. J. Cancer38, 1946–1950.10.1016/S0959-8049(02)00236-8Search in Google Scholar

Murthy, N.S.R.K., Bakeris, T., Kavarana, M.J., Hamilton, D.S., Lan, Y., and Creighton, D.J. (1994). S-(N-Aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II. J. Med. Chem.37, 2161–2166.10.1021/jm00040a007Search in Google Scholar

Olliaro, P. (2001). Mode of action and mechanism of resistance for antimalarial drugs. Pharmacol. Ther.89, 207–219.10.1016/S0163-7258(00)00115-7Search in Google Scholar

Ridderström, M. and Mannervik, B. (1996a). The primary structure of monomeric yeast glyoxalase I indicates a gene duplication resulting in two similar segments homologous to the subunit of dimeric human glyoxalase I. Biochem. J.316, 1005–1006.10.1042/bj3161005Search in Google Scholar PubMed PubMed Central

Ridderström, M. and Mannervik, B. (1996b). Optimized heterologous expression of the human zinc enzyme glyoxalase I. Biochem. J.314, 463–467.10.1042/bj3140463Search in Google Scholar PubMed PubMed Central

Ridderström, M., Saccucci, F., Hellman, U., Bergman, T., Principato, G., and Mannervik, B. (1996). Molecular cloning, heterologous expression and characterization of human glyoxalase II. J. Biol. Chem.271, 319–323.10.1074/jbc.271.1.319Search in Google Scholar

Ridderström, M., Jemth, P., Cameron, A.D., and Mannervik, B. (2000). The active-site residue Tyr-175 in human glyoxalase II contributes to binding of glutathione derivatives. Biochim. Biophys. Acta1481, 344–348.10.1016/S0167-4838(00)00178-3Search in Google Scholar

Schwede, T., Kopp, J., Guex, N., and Peitsch, M.C. (2003). SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res.31, 3381–3385.10.1093/nar/gkg520Search in Google Scholar

Sherman, I.W. (1979). Biochemistry of Plasmodium (malarial parasites). Microbiol. Rev.43, 453–495.10.1128/mr.43.4.453-495.1979Search in Google Scholar

Sommer, A., Fischer, P., Krause, K., Boettcher, K., Brophy, P.M., Walter, R.D., and Liebau, E. (2001). A stress-responsive glyoxalase I from the parasitic nematode Onchocerca volvulus. Biochem. J.353, 445–452.10.1042/bj3530445Search in Google Scholar

Sukdeo, N., Clugston, S.L., Daub, E., and Honek, J.F. (2004). Distinct classes of glyoxalase I. metal specificity of the Yersinia pestis, Pseudomonas aeruginosa and Neisseria meningitidis enzymes. Biochem. J.384, 111–117.Search in Google Scholar

Thornalley, P.J. (1993). The glyoxalase system in health and disease. Mol. Aspects Med.14, 287–371.10.1016/0098-2997(93)90002-USearch in Google Scholar

Thornalley, P.J. (1996). Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification–a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol.27, 565–573.10.1016/0306-3623(95)02054-3Search in Google Scholar

Thornalley, P.J. (1998). Glutathione dependent detoxification of α-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem. Biol. Interact.111–112, 137–151.10.1016/S0009-2797(97)00157-9Search in Google Scholar

Thornalley, P.J., Strath, M., and Wilson, R.J.M. (1994). Antimalarial activity in vitro of the glyoxalase I inhibitor diester, S-p-bromobenzylglutathione diethyl ester. Biochem. Pharmacol.47, 418–420.10.1016/0006-2952(94)90035-3Search in Google Scholar

Thornalley, P.J., Edwards, L.G., Kang, Y., Wyatt, C., Davies, N., Ladan, M.J., and Double, J. (1996). Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Biochem. Pharmacol.51, 1365–1372.10.1016/0006-2952(96)00059-7Search in Google Scholar

Trager, W. and Jensen, J.B. (1976). Human malaria parasites in continuous culture. Science193, 673–675.10.1126/science.781840Search in Google Scholar

Vaca, C.E., Fang, J.L., Conradi, M., and Hou, S.M. (1994). Development of a 32P-postlabelling method for the analysis of 2′-deoxyguanosine-3′-monophosphate and DNA adducts of methylglyoxal. Carcinogenesis15, 1887–1894.10.1093/carcin/15.9.1887Search in Google Scholar

Vander Jagt, D.L., Han, L-P.B., and Lehman, C.H. (1972). Kinetic evaluation of substrate specificity in the glyoxalase-I-catalyzed disproportionation of α-ketoaldehydes. Biochemistry11, 3735–3740.10.1021/bi00770a011Search in Google Scholar

Wenzel, N.F., Carenbauer, A.L., Pfiester, M.P., Schilling, O., Meyer-Klaucke, W., Makaroff, C.A., and Crowder, M.W. (2004). The binding of iron and zinc to glyoxalase II occurs exclusively as di-metal centers and is unique within the metallo-β-lactamase family. J. Biol. Inorg. Chem.9, 429–438.10.1007/s00775-004-0535-2Search in Google Scholar

Zuegge, J., Ralph, S., Schmuker, M., McFadden, G.I., and Schneider, G. (2001). Deciphering apicoplast targeting signals – feature extraction from nuclear-encoded precursors of Plasmodium falciparum apicoplast proteins. Gene280, 19–26.10.1016/S0378-1119(01)00776-4Search in Google Scholar

Published Online: 2005-06-01
Published in Print: 2005-01-01

©2004 by Walter de Gruyter Berlin New York

Downloaded on 23.4.2024 from https://www.degruyter.com/document/doi/10.1515/BC.2005.006/html
Scroll to top button